Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Map My Mole, by Community Dermatology Limited, is a service that offers remote assessments of moles and skin lesions by consultant dermatologists.
Their missions in to bring skin checks to where the patient is, whether at home or in one…
Working in collaboration with partners across health and care, its multi-disciplinary team carries out health technology assessments of health or care technologies that are not a medicine and publishes national guidance on their use in Wales.
Read more here.
Attendees
Sponsors and
Exhibitors
Webinars
Contact us